European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients

Eri Yamamoto(Yokohama City University), Yoshiaki Ishigatsubo(Yokohama City University), Masatsugu Tanaka(Kanagawa Prefectural Hospital Organization), Megumi Itabashi(Shizuoka Red Cross Hospital), Hideyuki Koharazawa(Yokohama City University Medical Center), Shin Fujisawa(Yokohama City University Medical Center), Takayoshi Tachibana(Yokohama City University), Naoto Tomita(St. Marianna University School of Medicine), Daisuke Ishibashi(Fukuoka University), Maki Hagihara(Yokohama City University Hospital), Hiroyuki Fujita(Kanazawa University), Rika Kawasaki(Yokohama City University Medical Center), Heiwa Kanamori(Kanagawa Prefectural Hospital Organization), Katsumichi Fujimaki(Fujisawa City Hospital), Kumiko Kishimoto(Hiratsuka City Hospital), Yuki Nakajima(Fujisawa City Hospital), Rika Sakai(Yokohama City University Medical Center), Hideyuki Kuwabara(Yokohama City University Medical Center), Etsuko Yamazaki(Yokohama City University), Chizuko Hashimoto(Yamato Municipal Hospital)
Cancer Science
November 8, 2013
Cited by 39


Related Papers